What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Immune system
His primary areas of investigation include Transplantation, Immunology, Internal medicine, Bone marrow and Stem cell.
His Transplantation study combines topics in areas such as Virology, Immunosuppression, Immune tolerance, Immune system and Fludarabine.
The study incorporates disciplines such as Graft-versus-host disease and Busulfan in addition to Immunology.
He combines subjects such as Gastroenterology, Transplantation Conditioning, Surgery and Oncology with his study of Internal medicine.
He has included themes like Cell therapy, Leukemia, Acute lymphocytic leukemia and Immunotherapy in his Bone marrow study.
His research in Stem cell intersects with topics in Cancer research and Mesenchymal stem cell.
His most cited work include:
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases (1962 citations)
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning (998 citations)
- Defining the intensity of conditioning regimens: working definitions. (975 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Transplantation, Bone marrow, Internal medicine and Stem cell.
Within one scientific family, Shimon Slavin focuses on topics pertaining to Haematopoiesis under Immunology, and may sometimes address concerns connected to Progenitor cell and Stromal cell.
He has researched Transplantation in several fields, including Regimen and Fludarabine.
The Bone marrow study combines topics in areas such as Spleen, Immunosuppression, Cytokine and T cell.
His Internal medicine research includes elements of Gastroenterology, Endocrinology, Surgery and Oncology.
The concepts of his Stem cell study are interwoven with issues in Cancer research and Mesenchymal stem cell.
He most often published in these fields:
- Immunology (54.12%)
- Transplantation (43.29%)
- Bone marrow (28.47%)
What were the highlights of his more recent work (between 2006-2020)?
- Immunology (54.12%)
- Transplantation (43.29%)
- Internal medicine (27.53%)
In recent papers he was focusing on the following fields of study:
Immunology, Transplantation, Internal medicine, Stem cell and Surgery are his primary areas of study.
His research in Immunology intersects with topics in Haematopoiesis and Graft-versus-host disease.
His Transplantation research integrates issues from Myeloid, Leukemia, Survival rate and Immunotherapy.
His Internal medicine research includes themes of Gastroenterology and Oncology.
His Stem cell research is multidisciplinary, incorporating perspectives in Cancer research, T cell, Toxicity, Mesenchymal stem cell and Bone marrow.
In his research on the topic of Hematopoietic stem cell transplantation, Survival analysis is strongly related with Transplantation Conditioning.
Between 2006 and 2020, his most popular works were:
- Defining the intensity of conditioning regimens: working definitions. (975 citations)
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency (814 citations)
- Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. (685 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Immune system
Shimon Slavin mainly focuses on Internal medicine, Stem cell, Transplantation, Immunology and Surgery.
The various areas that he examines in his Internal medicine study include Gastroenterology, Transplantation Conditioning, Oncology and Endocrinology.
Shimon Slavin has included themes like SOX2, Cancer research and Mesenchymal stem cell in his Stem cell study.
While the research belongs to areas of Transplantation, Shimon Slavin spends his time largely on the problem of Survival rate, intersecting his research to questions surrounding Cancer.
His work carried out in the field of Immunology brings together such families of science as Adverse effect, Intention-to-treat analysis and Neuroprotection.
The Surgery study combines topics in areas such as Paroxysmal nocturnal hemoglobinuria, Platelet, Peliosis hepatis and Lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
